Patents matching “cells”

US 6352694

Methods for inducing a population of T cells to proliferate using agents which recognize TCR/CD3 and ligands which stimulate an accessory molecule on the surface of the T cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Mar 5, 2002 · Expires Feb 28, 2022

US 6342216

Therapy of cancer by insect cells containing recombinant baculovirus encoding genes

The Board of Regents of the University of Texas System · Granted Jan 29, 2002 · Expires Jan 24, 2022

US 6326466

Double-stranded RNA dependent protein kinase derived peptides to promote proliferation of cells and tissues in a controlled manner

The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 4, 2001 · Expires Nov 29, 2021

US 6326198

Methods and compositions for the ex vivo replication of stem cells, for the optimization of hematopoietic progenitor cell cultures, and for increasing the metabolism, GM-CSF secretion and/or IL-6 secretion of human stromal cells

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 4, 2001 · Expires Nov 29, 2021

US 6319496

Generation of human cytotoxic T-cells specific for carcinoma self-associated antigens and uses thereof

The United States of America, as represented by the Department of Health and Human Services · Granted Nov 20, 2001 · Expires Nov 15, 2021

US 6316206

Method for screening comprising cells expressing the CNTF receptor

REGENERON PHARMACEUTICALS, INC. · Granted Nov 13, 2001 · Expires Nov 8, 2021

US 6300104

Secretory immunoglobulin produced by single cells and methods for making and using same

The Regents of the University of California · Granted Oct 9, 2001 · Expires Oct 4, 2021

US 6297219

Site-specific instillation of cells or site-specific transformation of cells and kits therefor

THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Oct 2, 2001 · Expires Sep 27, 2021

US 6287562

Methods of inhibiting the growth of cells bearing LewisY antigens using B1, B3, or B5 targeted immunoconjugates

The United States of America, as represented by the Department of Health and Human Services · Granted Sep 11, 2001 · Expires Sep 6, 2021

US 6287792

Drug delivery of antisense oligonucleotides and peptides to tissues in vivo and to cells using avidin-biotin technology

The Regents of the University of California · Granted Sep 11, 2001 · Expires Sep 6, 2021

US 6277368

Cancer immunotherapy using autologous tumor cells combined with cells expressing a membrane cytokine

The Regents of the University of California · Granted Aug 21, 2001 · Expires Aug 16, 2021

US 6261841

Compositions, kits, and methods for modulating survival and differentiation of multi-potential hematopoietic progenitor cells

The Board of Trustees of Northwestern University · Granted Jul 17, 2001 · Expires Jul 12, 2021

US 6262244

DNA and amino acid sequence specific for natural killer cells

Regents of the University of Minnesota · Granted Jul 17, 2001 · Expires Jul 12, 2021

US 6248791

Stimulating the differentiation of preadipocytic cells and therapies based thereon

Centre International de Recherches Dermatalogiques Galderma (C.I.R.D.) Galderma · Granted Jun 19, 2001 · Expires Jun 14, 2021

US 6248351

Human PEA3 is a tumor suppressor for cancer cells

The Board of Regents of the University of Texas System · Granted Jun 19, 2001 · Expires Jun 14, 2021

US 6245563

Enhanced activation of natural killer cells using an NK cell activator and hydrogen peroxide scavenger or inhibitor

Maxim Pharmaceuticals, Inc. · Granted Jun 12, 2001 · Expires Jun 7, 2021

US 6231852

Method for reducing BCL-2 expressing cells resistance to death

The Regents of the University of California · Granted May 15, 2001 · Expires May 10, 2021

US 6232086

Method for detecting cancer cells

The United States of America, as represented by the Department of Health and Human Services · Granted May 15, 2001 · Expires May 10, 2021

US 6214571

Method for inhibiting adenylosuccinate synthetase activity in malignant methylthioadenosine phosphorylase deficient cells

The Regents of the University of California · Granted Apr 10, 2001 · Expires Apr 5, 2021

US 6214388

Immunoliposomes that optimize internalization into target cells

The Regents of the University of California · Granted Apr 10, 2001 · Expires Apr 5, 2021

US 6210917

Method for suppressing multiple drug resistance in cancer cells

The Regents of the University of California · Granted Apr 3, 2001 · Expires Mar 29, 2021

US 6207412

Identification of a G protein-coupled receptor transcriptionally regulated by protein tyrosine kinase signaling in hematopoietic cells

The Regents of the University of California · Granted Mar 27, 2001 · Expires Mar 22, 2021

US 6207147

Cancer immunotherapy using tumor cells combined with mixed lymphocytes

The Regents of the University of California · Granted Mar 27, 2001 · Expires Mar 22, 2021

US 6203787

Treating tumors using implants comprising combinations of allogeneic cells

The Regents of the University of California · Granted Mar 20, 2001 · Expires Mar 15, 2021